AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 29(2), 1980, pp. 195-198
Copyright © 1980 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Desjeux, P.
Right arrow Articles by Capron, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Desjeux, P.
Right arrow Articles by Capron, A.

Circulating Immune Complexes and Anti-IgG Antibodies in Mucocutaneous Leishmaniasis*

Philippe Desjeux{dagger}, Ferrucio Santoro, Daniel Afchain, Marc Loyens AND André Capron
Centre d'Immunologie et de Biologie Parasitaire de l'Institut Pasteur de Lille, France

Circulating immune complexes (CIC), anti-IgG, anti-DNA, and anti-collagen autoantibodies (Ab) were investigated in sera from patients with South American leishmaniasis. No significant levels of anti-DNA or anti-collagen autoantibodies were observed. Only a few patients with cutaneous leishmaniasis or with only one mucocutaneous lesion showed values for CIC and anti-IgG Ab higher than those in the control group. In contrast, both CIC and anti-IgG Ab were demonstrated in most patients with several lesions due to mucocutaneous leishmaniasis (MMC). Moreover, a close correlation was noticed between the detection of CIC and anti-IgG Ab in MMC patients. This relationship suggested that part of the detected CIC could have been formed by IgG-anti-IgG complexes. The involvement of these immunopathologically active substances in the clinical evolution of mucocutaneous leishmaniasis is discussed.

Accepted for publication June 30, 1979.


* This investigation was supported by grants from the CNRS (ERA 422) and INSERM (U 167).

Address reprint requests to: Dr. Ferrucio Santoro, Centre d'Immunologie et de Biologie Parasitaire, Institut Pasteur, B.P. 3415, 59019—Lille Cedex, France.


{dagger} Present address: Institut Pasteur de Dakar, B.P. 220, Dakar, Senegal.




This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
J. R. Ryan, A. M. Smithyman, G-H. Rajasekariah, L. Hochberg, J. M. Stiteler, and S. K. Martin
Enzyme-Linked Immunosorbent Assay Based on Soluble Promastigote Antigen Detects Immunoglobulin M (IgM) and IgG Antibodies in Sera from Cases of Visceral and Cutaneous Leishmaniasis
J. Clin. Microbiol., March 1, 2002; 40(3): 1037 - 1043.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by the American Society of Tropical Medicine and Hygiene.